Xtant Medical Holdings (XTNT) Receivables (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Receivables data on file, last reported at $17.8 million in Q4 2025.

• On a quarterly basis, Receivables fell 19.44% year-over-year to $17.8 million in Q4 2025; TTM through Dec 2025 was $17.8 million, a 19.44% decrease from a year earlier, with the FY2025 full-year figure at $20.0 million, down 9.5% from the prior year.
• Receivables for Q4 2025 stood at $17.8 million, down from $25.5 million in the prior quarter.
• Over the last five years, Receivables for XTNT reached as high as $27.0 million in Q2 2025 and fell as low as $6.3 million in Q3 2021.
• Historically, Receivables has averaged $15.5 million across 5 years, with a median of $15.8 million in 2023.
• Across the five-year window, Receivables slipped 27.88% in 2021 and soared 99.94% in 2023, its largest moves.
• Year by year, Receivables stood at $7.2 million in 2021, then surged by 51.71% to $10.9 million in 2022, then surged by 99.94% to $21.7 million in 2023, then increased by 1.84% to $22.1 million in 2024, then retreated by 19.44% to $17.8 million in 2025.
• Per Business Quant data, the three most recent Receivables figures were $17.8 million in Q4 2025, $25.5 million in Q3 2025, and $27.0 million in Q2 2025.